South Korea Intravenous Iron Drugs Market Size & Outlook
South Korea intravenous iron drugs market, 2018-2030 (US$M)
Related Markets
South Korea intravenous iron drugs market highlights
- The South Korea intravenous iron drugs market generated a revenue of USD 2.9 million in 2023 and is expected to reach USD 5.6 million by 2030.
- The South Korea market is expected to grow at a CAGR of 9.9% from 2024 to 2030.
- In terms of segment, ferric carboxymaltose was the largest revenue generating product in 2023.
- Iron Sucrose is the most lucrative product segment registering the fastest growth during the forecast period.
Intravenous iron drugs market data book summary
| Market revenue in 2023 | USD 2.9 million |
| Market revenue in 2030 | USD 5.6 million |
| Growth rate | 9.9% (CAGR from 2023 to 2030) |
| Largest segment | Ferric carboxymaltose |
| Fastest growing segment | Iron Sucrose |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Iron Dextran, Iron Sucrose, Ferric Carboxymaltose |
| Key market players worldwide | AbbVie Inc, Civitas Resources Inc Ordinary Shares, Daiichi Sankyo Co Ltd, Sanofi SA, CSL Ltd, COSMOS Pharmaceutical Corp, Zydus Lifesciences, Rockwell Medical Inc |
Other key industry trends
- In terms of revenue, South Korea accounted for 0.1% of the global intravenous iron drugs market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan intravenous iron drugs market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 151.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Intravenous Iron Drugs Market Scope
Intravenous Iron Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Korea intravenous iron drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous iron drugs market will help companies and investors design strategic landscapes.
Ferric carboxymaltose was the largest segment with a revenue share of 41.38% in 2023. Horizon Databook has segmented the South Korea intravenous iron drugs market based on iron dextran, iron sucrose, ferric carboxymaltose covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in prevalence of cancer in the country is one of the major factors anticipated to boost the market in the near future. According to WHO, approximately 230,317 individuals were diagnosed with cancer. This included 25,814 breast cancer cases, 28,941 color ectum cancer cases, 28,651 lung cancer cases, 17,788 thyroid cancer cases, and 100,410 other cancer cases.
The same source mentioned that by 2025, the prevalence of cancer is expected to increase to 630,991 cases in the country. In addition, 88,597 deaths were recorded due to cancer in South Korea. Anemia in cancer patients is common and can have a negative impact on the quality of life & overall prognosis.
The pathogenesis is usually complex & multifactorial, with iron deficiency often being a major & potentially treatable contributor. Thus, growth in incidence of cancer is expected to enhance the adoption of IV iron drugs during the forecast period.
Reasons to subscribe to South Korea intravenous iron drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea intravenous iron drugs market databook
-
Our clientele includes a mix of intravenous iron drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea intravenous iron drugs market , including forecasts for subscribers. This country databook contains high-level insights into South Korea intravenous iron drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea intravenous iron drugs market size, by product, 2018-2030 (US$M)
South Korea Intravenous Iron Drugs Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
